Therapeutic Potential of P2X7 Purinergic Receptor Modulation in the Main Organs Affected by the COVID-19 Cytokine Storm
- PMID: 35838210
- DOI: 10.2174/1381612828666220713115906
Therapeutic Potential of P2X7 Purinergic Receptor Modulation in the Main Organs Affected by the COVID-19 Cytokine Storm
Abstract
Defined by the World Health Organization as a global public health pandemic, coronavirus 2019 (COVID-19) has a global impact and has caused the death of thousands of people. The "severe acute respiratory syndrome coronavirus 2" virus (SARS-CoV-2) is the etiologic agent of this disease, which uses the angiotensinconverting enzyme receptor 2 (ACE2) to infect the body, so any organ that expresses the gene ACE2 is a possible target for the new coronavirus. In addition, in severe cases of COVID-19, a cytokine storm occurs, which triggers widespread systemic inflammation due to the uncontrolled release of proinflammatory cytokines. In this perspective, the modulation of purinergic receptors is highlighted in the literature as a possible therapy, considering its application in other viral infections and systemic inflammation. Therefore, this review aims to gather information on the modulation of the P2X7 receptor in the main organs directly affected by the virus and by the cytokine storm: the heart, brain, lung, liver and kidneys. Thus, demonstrating possible therapies for reducing inflammation and the level of morbidity and mortality of COVID-19. In severe cases of COVID-19, SARS-CoV-2 infection is capable of triggering an exacerbated release of cytokines, called a cytokine storm. With this inflammation, or less the direct infection of the virus, the whole organism can be affected. In this way, major and important organs such as the heart, lung, brain, and liver are affected, triggering different pathologies. In this perspective, purinergic signaling is highlighted in the literature for its anti-inflammatory role and has been listed in the pandemic scenario as a potential therapy. Therefore, knowing the expression of the purinergic receptor P2X7 in these tissues, the modulation of its inflammatory activity may be favorable in this severe and systemic condition.
Keywords: COVID-19; P2X7; brain; heart; kidney; liver; therapeutic.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue.Int Immunopharmacol. 2021 Nov;100:108150. doi: 10.1016/j.intimp.2021.108150. Epub 2021 Sep 13. Int Immunopharmacol. 2021. PMID: 34537482 Free PMC article. Review.
-
Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection.Mol Neurobiol. 2021 Oct;58(10):5090-5111. doi: 10.1007/s12035-021-02464-0. Epub 2021 Jul 11. Mol Neurobiol. 2021. PMID: 34247339 Free PMC article. Review.
-
Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications.Inflammation. 2021 Feb;44(1):13-34. doi: 10.1007/s10753-020-01337-3. Epub 2020 Oct 8. Inflammation. 2021. PMID: 33029758 Free PMC article. Review.
-
Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges.World J Gastroenterol. 2021 Apr 21;27(15):1531-1552. doi: 10.3748/wjg.v27.i15.1531. World J Gastroenterol. 2021. PMID: 33958841 Free PMC article. Review.
-
A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling.Purinergic Signal. 2022 Mar;18(1):13-59. doi: 10.1007/s11302-021-09814-6. Epub 2021 Nov 10. Purinergic Signal. 2022. PMID: 34757513 Free PMC article. Review.
Cited by
-
Melatonin's Impact on Cytokine Storm and Modulation of Purinergic Receptors for COVID-19 Prognosis: A Mental Health Perspective.J Mol Neurosci. 2024 Dec 5;74(4):113. doi: 10.1007/s12031-024-02292-6. J Mol Neurosci. 2024. PMID: 39636363 Review.
-
Trends in Research on the P2X7 Receptor: A Bibliometric and Visualization Analysis.J Inflamm Res. 2025 May 16;18:6349-6362. doi: 10.2147/JIR.S522380. eCollection 2025. J Inflamm Res. 2025. PMID: 40395554 Free PMC article. Review.
-
Hypoxia signaling in cancer: HIF-1α stimulated by COVID-19 can lead to cancer progression and chemo-resistance in oral squamous cell carcinoma (OSCC).Discov Oncol. 2025 Mar 26;16(1):399. doi: 10.1007/s12672-025-02150-w. Discov Oncol. 2025. PMID: 40138101 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous